Clinical trials
COVID-19 clinical trials
Below are recruiting covid-19 clinical trials, each written for real people, not researchers. We’re tracking 273 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05890599Recruiting
Yoga or health education for ongoing fatigue after COVID
This trial studies whether a yoga program (compared with health education) can reduce persistent tiredness after COVID-19. It may help if your fatigue has lasted at least 12 weeks and you think it started with COVID.
StuttgartAges 18–65 - NCT05880108Recruiting
Behavior program to help COVID recovery in Veterans
This study tests whether a behavioral (lifestyle) program can improve recovery from COVID-19, especially for Veterans with different body weights. It looks at people who either have never had COVID before or had COVID more than 90 days ago.
Baltimore, MarylandAges Up to 80 years - NCT04858412Recruiting
Amino acid supplement to help people with COVID-19 and alcohol liver disease
This study tests whether an HMB-enriched amino acid supplement can improve outcomes in adults who have COVID-19 pneumonia, especially those with alcohol-related liver disease. The trial compares results in people with alcohol liver disease versus those without, to see if the supplement helps during recovery.
Cleveland, OhioAges 21 years+ - NCT04344119Recruiting
Study of chilblains during COVID-19 infection
This study looks at skin lesions (chilblains) that appear in people with a confirmed COVID-19 infection. It aims to better understand these skin changes.
NiceAges Up to 90 years - NCT03963622Recruiting
Test of careful breathing support for severe lung distress
This study compares a more careful ventilation approach for people with severe lung breathing failure (ARDS). It aims to improve outcomes by using a specific strategy for how the ventilator controls breathing.
New York, New YorkAges 18 years+ - NCT04978571Recruiting
Electrical nerve stimulation for long-lasting concussion symptoms
This study tests whether a device that delivers gentle electrical signals to nerves through the skin can help children and teens with concussion symptoms that have lasted at least 3 months. You may be asked to attend clinic visits for the nerve stimulation setup if you meet the safety and scheduling requirements.
Orange, CaliforniaAges 11–18 - NCT07417176Recruiting
Persistent COVID-19 registry study in Navarre
This study is a registry for people in Navarre, Spain, who have long-lasting COVID-19 symptoms (more than 3 months). By joining, you help doctors learn more about persistent COVID and how to care for it.
Pamplona, NavarreAges Any age - NCT06590324RecruitingPhase 2/Phase 3
Study of Apabetalone for long COVID
This trial tests an experimental drug called Apabetalone for people with long COVID. You may be eligible if you have type 2 diabetes, take or are willing to take dapagliflozin, and have had long COVID symptoms for at least 2 months after your COVID infection.
AmmanAges 18 years+ - NCT07197164RecruitingPhase 2
Remdesivir for kidney transplant patients with mild COVID-19
This trial tests whether giving remdesivir to kidney transplant patients who test positive for COVID-19 can prevent them from getting severely ill. It is for people who have already had at least three COVID-19 vaccine doses and are scheduled to receive a kidney transplant soon.
Badalona, BarcelonaAges 18 years+ - NCT05741112Recruiting
Long COVID wearable study to track symptoms and help daily management
This study uses a wearable device to track symptoms and patterns in people with Long COVID, ME/CFS, and/or POTS. The goal is to see how wearable feedback and tracking tools may help you manage your symptoms.
La Jolla, CaliforniaAges 18 years+ - NCT07051954Recruiting
Breathing muscle training for long COVID recovery
This study tests a special breathing and muscle training program to help people with long COVID feel better and move more easily. The training is designed to strengthen the muscles you use to breathe and to improve your daily function.
Ankara, ÇankayaAges 18–65 - NCT06528171Recruiting
Long COVID immunity and imaging study
This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.
NiceAges 18 years+ - NCT06716996Recruiting
Brain stimulation for mood problems after COVID-19
This study tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help people aged 18 to 65 who have ongoing depression or low mood for more than 12 weeks after a confirmed COVID-19 infection. The treatment uses magnetic pulses to gently stimulate parts of the brain involved in mood regulation.
Zurich, Canton of ZurichAges 18–65 - NCT07302295Recruiting
How COVID-19 affected suicidal behavior in kids
This study looks at how the COVID-19 pandemic affected suicidal behavior in children and teens. Researchers want to compare episodes that happened during the pandemic (2020-2022) with those just before (2018-2019) to understand if there was a change.
BronAges 8–18 - NCT06879925Recruiting
Qi-Gong therapy for long COVID recovery
This study tests whether gentle Qi-Gong exercises can improve physical health and quality of life for people with lingering COVID-19 symptoms (long COVID). It may help if you're over 20 and struggling with post-COVID issues.
New Taipei CityAges 20–100 - NCT07189936RecruitingPhase 2
Testing 2-HOBA for Immune Issues in Long COVID with POTS
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
Nashville, TennesseeAges 18 years+ - NCT07074158Enrolling by invitation
Looking for long COVID clues in blood
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
Palo Alto, CaliforniaAges 18 years+ - NCT06920628RecruitingPhase 1
Brain scan study for long COVID neurological symptoms
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Bethesda, MarylandAges 18–70 - NCT05787379Recruiting
Care program for Veterans with long-lasting COVID symptoms
This trial tests a care approach for Veterans who have long-COVID—aiming to improve symptoms and follow-up care through participating VA clinicians. You may be included if you are a Veteran with long-COVID and can be seen by a participating clinician soon, unless you had severe COVID requiring ICU care.
East Orange, New JerseyAges Any age - NCT06012552RecruitingPhase 2
Tianeptine for COVID-19 brain fog
This study tests whether the medication tianeptine can improve brain fog and thinking problems that persist after COVID-19. It may help if you are 18 or older, have had COVID-19, and have noticed new memory or concentration issues.
WarsawAges 18 years+ - NCT06248151Recruiting
Exercise and heart health after COVID-19
This study looks at how a single exercise session affects the heart and blood vessels in people with lasting COVID-19 symptoms. It may help understand if exercise is safe and helpful for recovery.
São PauloAges 18 years+ - NCT05898529Recruiting
Testing COVID status in children having surgery
This study looks at how COVID-19 infection is handled in children (ages 2–17) who are scheduled for surgery. The goal is to compare testing/safety approaches and see how they may protect pediatric surgical patients.
Surrey, British ColumbiaAges 2–17 - NCT06168006Recruiting
Exercise app for heart health after COVID
This study tests whether a smartphone exercise app can improve heart health and physical function in people who still have symptoms like fatigue or shortness of breath after COVID-19. If you qualify, you'll use the app to follow a home exercise program.
São Paulo, São PauloAges 18 years+ - NCT04459689Recruiting
COVID-19 study for people with primary immune deficiencies
This study looks at COVID-19 experiences in people who have a primary immune deficiency (a long-term immune problem) and who have had COVID-19. It may help researchers better understand how COVID-19 affects people with these conditions.
ParisAges birth+
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid-19?
- Yes. Clin2 currently lists 273 recruiting covid-19 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid-19 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid-19 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.